|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.48 INR | -2.32% |
|
+7.70% | +37.52% |
| Market Cap | 18.52B 193M 170M 159M 146M 272M 279M 1.88B 735M 9.16B 726M 710M 31.68B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 193M 170M 159M 146M 272M 279M 1.88B 735M 9.16B 726M 710M 31.68B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
56.3% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | -2.32% | ||
| 1 week | +7.70% | ||
| Current month | -4.51% | ||
| 1 month | -4.51% | ||
| 3 months | +36.39% | ||
| 6 months | +55.29% | ||
| Current year | +37.52% |
| 1 week | 51.43 |  | 57.98 |
| 1 month | 51.43 | | 64.57 |
| Current year | 33.44 | | 64.57 |
| 1 year | 33.44 | | 64.57 |
| 3 years | 29.51 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 57 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 57 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.32% | +7.70% | -5.35% | +81.61% | 331M | |
| -0.87% | +4.04% | +58.60% | +163.92% | 1,079B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 640B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -2.02% | +1.49% | +36.63% | +31.08% | 353B | |
| -1.60% | +0.09% | +34.48% | +40.31% | 301B | |
| -2.07% | +1.45% | +11.95% | +15.07% | 271B | |
| -1.58% | +3.95% | +2.45% | -39.03% | 228B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 209B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 165B | |
| Average | -1.40% | +5.20% | +27.83% | +55.64% | 371B | |
| Weighted average by Cap. | -1.18% | +4.87% | +41.34% | +77.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 178M 156M 146M 134M 250M 257M 1.73B 676M 8.42B 667M 653M 29.11B | 18.12B 189M 166M 155M 142M 266M 273M 1.84B 719M 8.96B 710M 695M 30.99B |
| Net income | 962M 10.04M 8.82M 8.23M 7.56M 14.15M 14.49M 97.64M 38.19M 476M 37.69M 36.87M 1.64B | 1.18B 12.32M 10.83M 10.11M 9.27M 17.36M 17.79M 120M 46.87M 584M 46.26M 45.26M 2.02B |
| Net Debt | 121M 1.26M 1.11M 1.03M 947K 1.77M 1.82M 12.24M 4.79M 59.65M 4.72M 4.62M 206M | -928K -9.69K -8.51K -7.95K -7.29K -13.65K -13.99K -94.23K -36.85K -459K -36.38K -35.59K -1.59M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
Aug. 04
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-30 | ₹56.48 | -2.32% | 208,296 |
| 26-07-29 | ₹57.82 | +4.58% | 218,851 |
| 26-07-28 | ₹55.29 | -2.30% | 217,508 |
| 26-07-27 | ₹56.59 | +5.21% | 503,493 |
| 26-07-24 | ₹53.79 | +2.57% | 427,315 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
